Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers.

Autor: Hilbers, Florentine S., Poncet, Coralie, Tryfonidis, Konstantinos, Viale, Giuseppe, Delaloge, Suzette, Pierga, Jean-Yves, Brain, Etienne G. C., Rubio, Isabel T., Thompson, Alastair M., Rutgers, Emiel J. T., Piccart, Martine J., van 't Veer, Laura J., Cardoso, Fatima
Zdroj: NPJ Breast Cancer; 11/2/2024, Vol. 10 Issue 1, p1-8, 8p
Databáze: Complementary Index
Externí odkaz: